Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID Reference, 4th edition, 372 pages

+ the daily Top 10

  Bladder Cancer

  Free Subscription

Articles published in Int Urol Nephrol

Retrieve available abstracts of 42 articles:
HTML format

Single Articles

    May 2020
  1. EL-HEFNAWY AS, Rizk EMAEA, Al Demerdash Khamis NM, Barakat MAA, et al
    Urinary hyaluronic acid: a versatile marker of bladder cancer.
    Int Urol Nephrol. 2020 May 1. pii: 10.1007/s11255-020-02480.
    PubMed     Abstract available

    March 2020
  2. ANDRADE DL, Moretti TBC, Neto WA, Benedetti J, et al
    Smoke load prognostic impact on bacillus Calmette-Guerin (BCG) treated non-muscle invasive bladder cancer.
    Int Urol Nephrol. 2020 Mar 10. pii: 10.1007/s11255-020-02438.
    PubMed     Abstract available

    February 2020
  3. MAZDAK H, Tolou Ghamari Z, Gholampour M
    Bladder cancer: total antioxidant capacity and pharmacotherapy with vitamin-E.
    Int Urol Nephrol. 2020 Feb 22. pii: 10.1007/s11255-020-02411.
    PubMed     Abstract available

  4. FENG D, Liu S, Tang Y, Yang Y, et al
    Comparison of perioperative and oncologic outcomes between robot-assisted and laparoscopic radical cystectomy for bladder cancer: a systematic review and updated meta-analysis.
    Int Urol Nephrol. 2020 Feb 20. pii: 10.1007/s11255-020-02406.
    PubMed     Abstract available

    November 2019
  5. YAMASHITA R, Nakamura M, Notsu A, Hashizume A, et al
    The occurrence of high-grade complications after radical cystectomy worsens oncological outcomes in patients with bladder cancer.
    Int Urol Nephrol. 2019 Nov 22. pii: 10.1007/s11255-019-02341.
    PubMed     Abstract available

  6. OTTOSSON K, Pelander S, Johansson M, Huge Y, et al
    The increased risk for thromboembolism pre-cystectomy in patients undergoing neoadjuvant chemotherapy for muscle-invasive urinary bladder cancer is mainly due to central venous access: a multicenter evaluation.
    Int Urol Nephrol. 2019 Nov 19. pii: 10.1007/s11255-019-02338.
    PubMed     Abstract available

  7. GULLU AMURAN G, Tinay I, Filinte D, Ilgin C, et al
    Urinary micro-RNA expressions and protein concentrations may differentiate bladder cancer patients from healthy controls.
    Int Urol Nephrol. 2019 Nov 2. pii: 10.1007/s11255-019-02328.
    PubMed     Abstract available

  8. KHALIL MI, Alliston JT, Bauer-Erickson JJ, Davis R, et al
    Organ-sparing procedures in GU cancer: part 3-organ-sparing procedures in urothelial cancer of upper tract, bladder and urethra.
    Int Urol Nephrol. 2019;51:1903-1911.
    PubMed     Abstract available

    October 2019
  9. GORGEL SN, Akin Y, Koc EM, Kose O, et al
    Retrospective study of systemic immune-inflammation index in muscle invasive bladder cancer: initial results of single centre.
    Int Urol Nephrol. 2019 Oct 28. pii: 10.1007/s11255-019-02325.
    PubMed     Abstract available

  10. MCFERRIN C, Raza SJ, May A, Davaro F, et al
    Charlson comorbidity score is associated with readmission to the index operative hospital after radical cystectomy and correlates with 90-day mortality risk.
    Int Urol Nephrol. 2019;51:1755-1762.
    PubMed     Abstract available

    August 2019
  11. PARIKH N, Sharma P
    Frailty as a prognostic indicator in the radical cystectomy population: a review.
    Int Urol Nephrol. 2019;51:1281-1290.
    PubMed     Abstract available

    June 2019
  12. XU R, Li H, Wu S, Qu J, et al
    MicroRNA-1246 regulates the radio-sensitizing effect of curcumin in bladder cancer cells via activating P53.
    Int Urol Nephrol. 2019 Jun 24. pii: 10.1007/s11255-019-02210.
    PubMed     Abstract available

  13. WU J, Wang YC, Dai B, Ye DW, et al
    Optical biopsy of bladder cancer using confocal laser endomicroscopy.
    Int Urol Nephrol. 2019 Jun 13. pii: 10.1007/s11255-019-02197.
    PubMed     Abstract available

  14. WU S, Lin SX, Lu M, Subtelny AO, et al
    Assessment of 5-year overall survival in bladder cancer patients with incidental prostate cancer identified at radical cystoprostatectomy.
    Int Urol Nephrol. 2019 Jun 10. pii: 10.1007/s11255-019-02181.
    PubMed     Abstract available

  15. SLUSARCZYK A, Zapala P, Zapala L, Piecha T, et al
    Prediction of BCG responses in non-muscle-invasive bladder cancer in the era of novel immunotherapeutics.
    Int Urol Nephrol. 2019 Jun 1. pii: 10.1007/s11255-019-02183.
    PubMed     Abstract available

  16. TSATURYAN A, Sahakyan S, Muradyan A, Fanarjyan S, et al
    A new modification of tubeless cutaneous ureterostomy following radical cystectomy.
    Int Urol Nephrol. 2019;51:959-967.
    PubMed     Abstract available

    May 2019
  17. TSENG WH, Liu CL, Huang SK, Liao AC, et al
    Therapeutic benefit of second-look transurethral resection of bladder tumors for newly diagnosed T1 bladder cancer: a single-center experience.
    Int Urol Nephrol. 2019 May 25. pii: 10.1007/s11255-019-02172.
    PubMed     Abstract available

    April 2019
  18. MAO W, Ma B, Huang X, Gu S, et al
    Which treatment is best for patients with AJCC stage IV bladder cancer?
    Int Urol Nephrol. 2019 Apr 4. pii: 10.1007/s11255-019-02105.
    PubMed     Abstract available

  19. MILOJEVIC B, Dzamic Z, Bojanic N, Durutovic O, et al
    Urothelial carcinoma of the upper urinary tract: preoperative pyuria is not correlated with bladder cancer recurrence and survival.
    Int Urol Nephrol. 2019 Apr 1. pii: 10.1007/s11255-019-02133.
    PubMed     Abstract available

    January 2019
  20. AMINI E, Ahmadi N, Clifford TG, Hugen CM, et al
    Long term oncologic outcome in patients with bladder cancer after radical cystectomy: Impact of carcinoma in situ in the era of neoadjuvant chemotherapy.
    Int Urol Nephrol. 2019 Jan 31. pii: 10.1007/s11255-019-02087.
    PubMed     Abstract available

    November 2018
  21. ZEWIN TS, El-Assmy A, Harraz AM, Bazeed M, et al
    Efficacy and safety of low-intensity shock wave therapy in penile rehabilitation post nerve-sparing radical cystoprostatectomy: a randomized controlled trial.
    Int Urol Nephrol. 2018;50:2007-2014.
    PubMed     Abstract available

    August 2018
  22. CAO J, Wang Q, Wu G, Li S, et al
    miR-129-5p inhibits gemcitabine resistance and promotes cell apoptosis of bladder cancer cells by targeting Wnt5a.
    Int Urol Nephrol. 2018 Aug 16. pii: 10.1007/s11255-018-1959.
    PubMed     Abstract available

  23. JURI H, Koyama M, Azuma H, Narumi Y, et al
    Are there any metastases to the chest in non-muscle-invasive bladder cancer patients on follow-up computed tomography?
    Int Urol Nephrol. 2018 Aug 16. pii: 10.1007/s11255-018-1952.
    PubMed     Abstract available

  24. TEKE K, Yilmaz H, Uslubas AK, Akpinar G, et al
    Histopathologic and molecular comparative analyses of intravesical Aurora kinase-A inhibitor Alisertib with bacillus Calmette-Guerin on precancerous lesions of bladder in a rat model.
    Int Urol Nephrol. 2018;50:1417-1425.
    PubMed     Abstract available

    April 2018
  25. BATURA D, Hashemzehi T, Colemeadow J
    A care bundle to improve perioperative mitomycin use in non-muscle-invasive bladder cancer.
    Int Urol Nephrol. 2018 Apr 2. pii: 10.1007/s11255-018-1863.
    PubMed     Abstract available

  26. WASEN C, Ekstrand M, Levin M, Giglio D, et al
    Epidermal growth factor receptor function in the human urothelium.
    Int Urol Nephrol. 2018;50:647-656.
    PubMed     Abstract available

    February 2018
  27. ZHANG J, Wang L, Mao S, Liu M, et al
    Transurethral en bloc resection with bipolar button electrode for non-muscle invasive bladder cancer.
    Int Urol Nephrol. 2018 Feb 24. pii: 10.1007/s11255-018-1830.
    PubMed     Abstract available

  28. WANG Z, Li C, Jiang M, Chen J, et al
    Filamin A (FLNA) regulates autophagy of bladder carcinoma cell and affects its proliferation, invasion and metastasis.
    Int Urol Nephrol. 2018;50:263-273.
    PubMed     Abstract available

  29. MARUF M, Sidana A, Purnell S, Jain AL, et al
    Lymph node dissection during radical cystectomy following prior radiation therapy: results from the SEER database.
    Int Urol Nephrol. 2018;50:257-262.
    PubMed     Abstract available

    July 2017
  30. VAN DE PUTTE EEF, Vegt E, Mertens LS, Bruining A, et al
    FDG-PET/CT for response evaluation of invasive bladder cancer following neoadjuvant chemotherapy.
    Int Urol Nephrol. 2017 Jul 3. doi: 10.1007/s11255-017-1637.
    PubMed     Abstract available

    March 2017
  31. BOTHIG R, Kurze I, Fiebag K, Kaufmann A, et al
    Clinical characteristics of bladder cancer in patients with spinal cord injury: the experience from a single centre.
    Int Urol Nephrol. 2017 Mar 22. doi: 10.1007/s11255-017-1570.
    PubMed     Abstract available

  32. YAMASHITA R, Watanabe R, Ito I, Shinsaka H, et al
    Risk factors for intravesical recurrence after nephroureterectomy in patients with upper urinary tract urothelial carcinoma.
    Int Urol Nephrol. 2017;49:425-430.
    PubMed     Abstract available

    February 2017
  33. SONG W, Jeon HG, Jeong BC, Seo SI, et al
    Clinical significance of incidentally detected bladder wall thickening on computed tomography.
    Int Urol Nephrol. 2017;49:191-196.
    PubMed     Abstract available

  34. GONDO T, Ohno Y, Nakashima J, Hashimoto T, et al
    Preoperative determinant of early postoperative renal function following radical cystectomy and intestinal urinary diversion.
    Int Urol Nephrol. 2017;49:233-238.
    PubMed     Abstract available

    January 2017
  35. MAHMOUD O, El-Assmy A, Kamal M, Ashamallah A, et al
    Is chronic alkali therapy in orthotopic ileal neobladders necessary? A prospective controlled study.
    Int Urol Nephrol. 2017;49:49-53.
    PubMed     Abstract available

    December 2016
  36. OTTO W, Breyer J, Herdegen S, Eder F, et al
    WHO 1973 grade 3 and infiltrative growth pattern proved, aberrant E-cadherin expression tends to be of predictive value for progression in a series of stage T1 high-grade bladder cancer after organ-sparing approach.
    Int Urol Nephrol. 2016 Dec 29. doi: 10.1007/s11255-016-1491.
    PubMed     Abstract available

    November 2016
  37. MAY M, Protzel C, Vetterlein MW, Gierth M, et al
    Is there evidence for a close connection between side of intravesical tumor location and ipsilateral lymphatic spread in lymph node-positive bladder cancer patients at radical cystectomy? Results of the PROMETRICS 2011 database.
    Int Urol Nephrol. 2016.
    PubMed     Abstract available

    October 2016
  38. LI HM, Azhati B, Rexiati M, Wang WG, et al
    Impact of smoking status and cumulative smoking exposure on tumor recurrence of non-muscle-invasive bladder cancer.
    Int Urol Nephrol. 2016.
    PubMed     Abstract available

    September 2016
  39. MAURICE MJ, Kim SP, Abouassaly R
    Socioeconomic status is associated with urinary diversion utilization after radical cystectomy for bladder cancer.
    Int Urol Nephrol. 2016.
    PubMed     Abstract available

    May 2016
  40. TONYALI S, Yazici S
    Does solitary- and organ-confined metastasectomy really improve survival in advanced urologic malignancies?
    Int Urol Nephrol. 2016;48:671-80.
    PubMed     Abstract available

    April 2016
  41. JO JK, Jeong SJ, Hong SK, Byun SS, et al
    The impact of preoperative anemia on oncologic outcome in patients undergoing radical cystectomy for urothelial carcinoma of the bladder.
    Int Urol Nephrol. 2016;48:489-94.
    PubMed     Abstract available

  42. ROBINSON R, Tait CD, Somov P, Lau MW, et al
    Estimated glomerular filtration rate is unreliable in detecting renal function loss during follow-up after cystectomy and urinary diversion.
    Int Urol Nephrol. 2016;48:511-5.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Bladder Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.